Clinical Trials
11
Active:0
Completed:10
Trial Phases
2 Phases
Phase 2:1
Phase 4:1
Drug Approvals
525
CANADA:262
NMPA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 4
1 (50.0%)Golimumab for Adherence in Rheumatoid Arthritis
Completed
- Conditions
- Arthritis, Rheumatoid
- First Posted Date
- 2018-11-02
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Janssen Inc.
- Target Recruit Count
- 222
- Registration Number
- NCT03729349
- Locations
- 🇨🇦
Peak Medical Specialty Centre, Calgary, Alberta, Canada
🇨🇦Jacqueline C Stewart Medical Inc., Penticton, British Columbia, Canada
🇨🇦Dr. Milton F Baker Inc., Victoria, British Columbia, Canada
A Study of Participants With Advanced Prostate Cancer in Canada
Completed
- Conditions
- Prostatic Neoplasms
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2023-07-25
- Lead Sponsor
- Janssen Inc.
- Target Recruit Count
- 374
- Registration Number
- NCT03501173
- Locations
- 🇨🇦
Tom Baker Cancer Center, Calgary, Alberta, Canada
🇨🇦Prostate Cancer Centre, Calgary, Alberta, Canada
🇨🇦University of Alberta, Edmonton, Alberta, Canada
An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in Canada
Completed
- Conditions
- Diabetes Mellitus, Type 2
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2017-10-30
- Lead Sponsor
- Janssen Inc.
- Target Recruit Count
- 538
- Registration Number
- NCT02688075
Observational Study of Golimumab Intravenous Infusion
Terminated
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2015-03-17
- Last Posted Date
- 2016-11-17
- Lead Sponsor
- Janssen Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT02390700
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology Setting
Completed
- Conditions
- Prostatic Neoplasms
- First Posted Date
- 2015-02-18
- Last Posted Date
- 2019-12-06
- Lead Sponsor
- Janssen Inc.
- Target Recruit Count
- 194
- Registration Number
- NCT02364531
- Prev
- 1
- 2
- 3
- Next
News
Supreme Court of Canada to Rule on Medical Treatment Patent Eligibility in Landmark Pharmascience v Janssen Case
The Supreme Court of Canada will hear arguments on October 9, 2025, in Pharmascience Inc. v Janssen Inc., addressing whether patents can validly claim methods of medical treatment, particularly dosing regimens.